{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:28:34Z","timestamp":1792290514517,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571407"],"award-info":[{"award-number":["31571407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["06172956"],"award-info":[{"award-number":["06172956"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112214","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T19:21:18Z","timestamp":1632252078000},"page":"112214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies"],"prefix":"10.1016","volume":"143","author":[{"given":"Chui Yan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan Joyce","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhou","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"100","key":"10.1016\/j.biopha.2021.112214_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.biopha.2021.112214_bib2","first-page":"606","article-title":"Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history, Nature reviews","volume":"12","author":"Kemp","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib3","first-page":"94","article-title":"Adulthood leukodystrophies, Nature reviews","volume":"14","author":"K\u00f6hler","year":"2018","journal-title":"Neurology"},{"issue":"26","key":"10.1016\/j.biopha.2021.112214_bib4","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","article-title":"Impaired very long-chain acyl-CoA \u03b2-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction","volume":"288","author":"Wiesinger","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154597","article-title":"C26:0-carnitine is a new biomarker for x-linked adrenoleukodystrophy in mice and man","volume":"11","author":"van de Beek","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-4347(01)00263-8","article-title":"Diagnostic patterns of very-long-chain fatty acids in plasma of patients with X-linked adrenoleukodystrophy","volume":"760","author":"Paik","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"15","key":"10.1016\/j.biopha.2021.112214_bib7","doi-asserted-by":"crossref","first-page":"e1698","DOI":"10.1212\/WNL.0000000000007294","article-title":"MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy","volume":"92","author":"Liberato","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/1817-1745.123661","article-title":"Childhood adrenoleukodystrophy - Classic and variant - Review of clinical manifestations and magnetic resonance imaging","volume":"8","author":"Santosh Rai","year":"2013","journal-title":"J. Pediatr. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib9","article-title":"MRI demyelination pattern and clinical course in a child with cerebral X-linked adrenoleukodystrophy (X-ALD)","volume":"4","author":"Nowak","year":"2015","journal-title":"Acta Radiol. Open"},{"issue":"Pt 6","key":"10.1016\/j.biopha.2021.112214_bib10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/brain\/aww068","article-title":"Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes","volume":"139","author":"Castellano","year":"2016","journal-title":"Brain J. Neurol."},{"issue":"24","key":"10.1016\/j.biopha.2021.112214_bib11","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.0000000000001074","article-title":"Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy","volume":"83","author":"de Beer","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","article-title":"X-linked adrenoleukodystrophy in women: a cross-sectional cohort study","volume":"137","author":"Engelen","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1008-6","article-title":"Disease progression in women with X-linked adrenoleukodystrophy is slow","volume":"14","author":"Huffnagel","year":"2019","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2018-01307","article-title":"The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration","volume":"104","author":"Huffnagel","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.biopha.2021.112214_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","article-title":"X-linked adrenoleukodystrophy: pathogenesis and treatment","volume":"14","author":"Engelen","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awy299","article-title":"Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness","volume":"142","author":"Huffnagel","year":"2019","journal-title":"Brain J. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jimd.12226","article-title":"Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy","volume":"43","author":"van de Stadt","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib18","first-page":"239","article-title":"Generalized skin hyperpigmentation as the only manifestation of X-linked adrenoleucodystrophy","volume":"182","author":"Lee","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/glia.23598","article-title":"Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy","volume":"67","author":"Bergner","year":"2019","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.21391","article-title":"Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?","volume":"63","author":"Eichler","year":"2008","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112214_bib21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awy127","article-title":"Impaired plasticity of macrophages in X-linked adrenoleukodystrophy","volume":"141","author":"Weinhofer","year":"2018","journal-title":"Brain J. Neurol."},{"issue":"Pt 11","key":"10.1016\/j.biopha.2021.112214_bib22","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/awv250","article-title":"Brain endothelial dysfunction in cerebral adrenoleukodystrophy","volume":"138","author":"Musolino","year":"2015","journal-title":"Brain J. Neurol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112214_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbadis.2012.02.005","article-title":"Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?","volume":"1822","author":"Galea","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10571-015-0234-2","article-title":"Oxidative stress in patients with x-linked adrenoleukodystrophy","volume":"36","author":"Deon","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jnc.12992","article-title":"ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy","volume":"133","author":"Baarine","year":"2015","journal-title":"J. Neurochem."},{"issue":"Pt A","key":"10.1016\/j.biopha.2021.112214_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2015.05.041","article-title":"Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: a paradigm for axonal degeneration","volume":"88","author":"Fourcade","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymgme.2013.05.009","article-title":"Glutathione imbalance in patients with X-linked adrenoleukodystrophy","volume":"109","author":"Petrillo","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/nan.12399","article-title":"Heat shock protein expression in cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss","volume":"44","author":"G\u00f6rtz","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.biopha.2021.112214_bib29","first-page":"109","article-title":"The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis","volume":"8","author":"Wiesinger","year":"2015","journal-title":"Appl. Clin. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib30","first-page":"36","article-title":"Clinical phenotype in two siblings with x-linked adrenoleukodystrophy","volume":"40","author":"Ozdemir Kutbay","year":"2019","journal-title":"Neuro Endocrinol. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410400221","article-title":"Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype","volume":"40","author":"Korenke","year":"1996","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.1220","article-title":"Monozygotic twins with X-linked adrenoleukodystrophy and different phenotypes","volume":"50","author":"Di Rocco","year":"2001","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","article-title":"Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis","volume":"20","author":"Singh","year":"2010","journal-title":"Brain Pathol."},{"issue":"26","key":"10.1016\/j.biopha.2021.112214_bib34","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2012.03.019","article-title":"The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy","volume":"106","author":"Rockenbach","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10545-014-9797-1","article-title":"Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study","volume":"38","author":"van Geel","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awx016","article-title":"Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy","volume":"140","author":"K\u00fchl","year":"2017","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.biopha.2021.112214_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.12659\/PJR.893285","article-title":"The role of MR imaging in the assessment of clinical outcomes in children with X-linked adrenoleukodystrophy after allogeneic haematopoietic stem\u00a0cell transplantation","volume":"80","author":"Bladowska","year":"2015","journal-title":"Pol. J. Radiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0769","article-title":"Potential risks to stable long-term outcome of allogeneic hematopoietic stem cell transplantation for children with cerebral X-linked adrenoleukodystrophy","volume":"1","author":"K\u00fchl","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib40","first-page":"1945","article-title":"Clinical characteristics and phenotype distribution in 10 Chinese patients with X-linked adrenoleukodystrophy","volume":"18","author":"Jia","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2021.112214_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-386509-0.00010-7","article-title":"Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy","volume":"507","author":"Cartier","year":"2012","journal-title":"Methods Enzymol."},{"issue":"17","key":"10.1016\/j.biopha.2021.112214_bib42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5954","key":"10.1016\/j.biopha.2021.112214_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","article-title":"Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients","volume":"26","author":"Marcucci","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"10","key":"10.1016\/j.biopha.2021.112214_bib45","article-title":"The old and the new: prospects for non-integrating lentiviral vector technology","volume":"12","author":"Luis","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1194\/jlr.M044586","article-title":"Lorenzo\u2019s oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid","volume":"55","author":"Sassa","year":"2014","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12031-007-0041-4","article-title":"\u201cLorenzo\u2019s oil\u201d therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy","volume":"33","author":"Moser","year":"2007","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5114\/fn.2014.43787","article-title":"Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo\u2019s Oil","volume":"52","author":"Stradomska","year":"2014","journal-title":"Folia Neuropathol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib49","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/bcp.12897","article-title":"A model-based approach to assess the exposure-response relationship of Lorenzo\u2019s oil in adrenoleukodystrophy","volume":"81","author":"Ahmed","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11011-007-9079-9","article-title":"Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo\u2019s oil effect","volume":"23","author":"Deon","year":"2008","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/LBR.0000000000000084","article-title":"Lipoid pneumonia as a complication of Lorenzo\u2019s oil therapy in a patient with adrenoleukodystrophy","volume":"21","author":"Majori","year":"2014","journal-title":"J. Bronchol. Interv. Pulmonol."},{"issue":"17","key":"10.1016\/j.biopha.2021.112214_bib52","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","article-title":"A mouse model for X-linked adrenoleukodystrophy","volume":"94","author":"Lu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W","article-title":"Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice","volume":"50","author":"Forss-Petter","year":"1997","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/bbrc.1997.6340","article-title":"Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism","volume":"232","author":"Kobayashi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.410160603","article-title":"Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy","volume":"16","author":"Moser","year":"1984","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","article-title":"Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy","volume":"11","author":"Pujol","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"23","key":"10.1016\/j.biopha.2021.112214_bib57","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","article-title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy","volume":"13","author":"Pujol","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2021.112214_bib58","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bbadis.2012.02.009","article-title":"Peroxisomal ABC transporters: structure, function and role in disease","volume":"1822","author":"Morita","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2021.112214_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6786245","article-title":"ABC transporter subfamily D: distinct differences in behavior between ABCD1-3 and ABCD4 in subcellular localization, function, and human disease","volume":"2016","author":"Kawaguchi","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"18","key":"10.1016\/j.biopha.2021.112214_bib60","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1093\/hmg\/ddx249","article-title":"A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination","volume":"26","author":"Strachan","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2021.112214_bib61","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.freeradbiomed.2020.01.177","article-title":"The peroxisomal fatty acid transporter ABCD1\/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: a worm model for adrenoleukodystrophy","volume":"152","author":"Coppa","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib62","first-page":"377","article-title":"Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases","volume":"9","author":"Sivachenko","year":"2016","journal-title":"Dis. Models Mech."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib63","article-title":"Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila","volume":"11","author":"Gordon","year":"2018","journal-title":"Dis. Models Mech."},{"issue":"11","key":"10.1016\/j.biopha.2021.112214_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143238","article-title":"Functional characterization of IPSC-derived brain cells as a model for X-linked adrenoleukodystrophy","volume":"10","author":"Baarine","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112214_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.scr.2017.10.003","article-title":"Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN)","volume":"25","author":"Son","year":"2017","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.biopha.2021.112214_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101425","article-title":"Generation of an induced pluripotent stem cell (iPSC) line from a 42-year-old adult cerebral type X-linked adrenoleukodystrophy (X-ALD) patient","volume":"36","author":"Yeon","year":"2019","journal-title":"Stem Cell Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.112214_bib67","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1248\/bpb.b12-00411","article-title":"Very long chain fatty acid \u03b2-oxidation in astrocytes: contribution of the ABCD1-dependent and -independent pathways","volume":"35","author":"Morita","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.biopha.2021.112214_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108655","article-title":"Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice","volume":"9","author":"Muneer","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib69","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy","volume":"23","author":"Gong","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/hum.2018.079","article-title":"Intrathecal adeno-associated viral vector-mediated gene delivery for adrenomyeloneuropathy","volume":"30","author":"Gong","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib71","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/en.2016-1842","article-title":"Hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy","volume":"158","author":"Hartley","year":"2017","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.chembiol.2020.02.008","article-title":"Pharmacological complementation remedies an inborn error of lipid metabolism","volume":"27","author":"Hartley","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"Pt 12","key":"10.1016\/j.biopha.2021.112214_bib73","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/brain\/aws292","article-title":"Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy","volume":"135","author":"L\u00f3pez-Erauskin","year":"2012","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.biopha.2021.112214_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijdevneu.2015.03.004","article-title":"Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients","volume":"43","author":"Marchetti","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2021.112214_bib75","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708604","article-title":"Aberrant regulation of the GSK-3\u03b2\/NRF2 axis unveils a novel therapy for adrenoleukodystrophy","volume":"10","author":"Ranea-Robles","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"Pt 8","key":"10.1016\/j.biopha.2021.112214_bib76","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awt143","article-title":"Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy","volume":"136","author":"Morat\u00f3","year":"2013","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715762.2019.1612891","article-title":"Biotin attenuation of oxidative stress, mitochondrial dysfunction, lipid metabolism alteration and 7\u03b2-hydroxycholesterol-induced cell death in 158N murine oligodendrocytes","volume":"53","author":"Sghaier","year":"2019","journal-title":"Free Radic. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib78","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/bpa.12869","article-title":"High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy","volume":"30","author":"Fourcade","year":"2020","journal-title":"Brain Pathol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112214_bib79","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.bbadis.2017.06.003","article-title":"Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy","volume":"1863","author":"van de Beek","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-016-1655-9","article-title":"Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy","volume":"133","author":"Launay","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112214_bib81","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/alzrt217","article-title":"Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease","volume":"5","author":"Orr","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib83","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1042\/BST20130134","article-title":"Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers","volume":"41","author":"Sarkar","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2021.112214_bib84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2019.04.016","article-title":"Protective function of autophagy during VLCFA-induced cytotoxicity in a neurodegenerative cell model","volume":"137","author":"Doria","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-014-1378-8","article-title":"Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy","volume":"129","author":"Launay","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib86","first-page":"1167","article-title":"Biomarker identification, safety, and efficacy of high-dose antioxidants for adrenomyeloneuropathy: a phase II pilot study","volume":"16","author":"Casasnovas","year":"2019","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","article-title":"Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy","volume":"70","author":"L\u00f3pez-Erauskin","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.06.019","article-title":"The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy","volume":"59","author":"Ciftciler","year":"2020","journal-title":"Transfus. Apher. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pediatrneurol.2015.05.002","article-title":"Combination of a haploidentical stem cell transplant with umbilical cord blood for cerebral X-linked adrenoleukodystrophy","volume":"53","author":"Jiang","year":"2015","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41409-017-0015-2","article-title":"Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation","volume":"53","author":"Fernandes","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib91","first-page":"409","article-title":"Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy","volume":"51","author":"Chen","year":"2019","journal-title":"Beijing da xue xue bao. Yi xue Ban. = J. Peking. Univ. Health Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2017.0013","article-title":"Neurocognitive trajectory of boys who received a hematopoietic stem cell transplant at an early stage of childhood cerebral adrenoleukodystrophy","volume":"74","author":"Pierpont","year":"2017","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib93","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","article-title":"Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation","volume":"25","author":"Raymond","year":"2019","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.biopha.2021.112214_bib94","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1111\/j.1399-3046.2009.01188.x","article-title":"Successful cord blood transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy","volume":"15","author":"Awaya","year":"2011","journal-title":"Pediatr. Transplant."},{"issue":"2","key":"10.1016\/j.biopha.2021.112214_bib95","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1111\/j.1399-3046.2011.01539.x","article-title":"Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages","volume":"16","author":"Niizuma","year":"2012","journal-title":"Pediatr. Transplant."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib96","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/acn3.51015","article-title":"Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy","volume":"7","author":"Zierfuss","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib97","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib98","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20356","article-title":"Evaluation of X-linked adrenoleukodystrophy newborn screening in North Carolina","volume":"3","author":"Lee","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2021.112214_bib99","first-page":"115","article-title":"Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy","volume":"12","author":"Wu","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.biopha.2021.112214_bib100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fcell.2020.00499","article-title":"Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor","volume":"8","author":"Barendsen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112214_bib101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2021.112214_bib102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2018.00239","article-title":"Beyond the blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma","volume":"8","author":"Warren","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112214_bib103","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2008.09.092","article-title":"X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype","volume":"377","author":"Maier","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2021.112214_bib104","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bbalip.2019.02.006","article-title":"CRISPR\/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy","volume":"1864","author":"Raas","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.biopha.2021.112214_bib105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2017.08.012","article-title":"X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans","volume":"122","author":"Curiel","year":"2017","journal-title":"Mol. Genet. Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:50:34Z","timestamp":1771919434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221009987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":105,"alternative-id":["S0753332221009987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112214","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112214"}}